Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 27.87% is 175% above its 5-year average of -37.39%, near the high end of its 5-year range (-124.71%–27.87%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.66% above its 12-month average of 23.49%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 27.87%.
RETURN ON INVESTED CAPITAL (ROIC)
27.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
23.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-30.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-37.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-54.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-79.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.66%
CURRENT VS 3Y AVG
+191.40%
CURRENT VS 5Y AVG
+174.53%
CURRENT VS 10Y AVG
+151.52%
CURRENT VS 15Y AVG
+135.24%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.43%
median of 512 covered companies
CURRENT VS SECTOR MEDIAN
+194.71%
vs the sector median at left
CorMedix Inc.
Market Cap
$564.85M
Return on Invested Capital (ROIC)
27.87%
TTM Avg
23.49%
3Y Avg
-30.49%
5Y Avg
-37.39%
Market Cap
$559.96M
Return on Invested Capital (ROIC)
-43.41%
TTM Avg
-39.91%
3Y Avg
-39.91%
5Y Avg
-39.91%
Market Cap
$573.38M
Return on Invested Capital (ROIC)
-45.62%
TTM Avg
-46.61%
3Y Avg
-61.97%
5Y Avg
-71.18%
Market Cap
$580.12M
Return on Invested Capital (ROIC)
-56.99%
TTM Avg
-66.45%
3Y Avg
-57.50%
5Y Avg
-60.06%
Market Cap
$554.05M
Return on Invested Capital (ROIC)
-25.42%
TTM Avg
25.46%
3Y Avg
-12.61%
5Y Avg
-20.42%
Market Cap
$546.13M
Return on Invested Capital (ROIC)
-0.81%
TTM Avg
-8.59%
3Y Avg
-110.96%
5Y Avg
-102.03%
Market Cap
$540.75M
Return on Invested Capital (ROIC)
-18.20%
TTM Avg
-95.31%
3Y Avg
-87.63%
5Y Avg
-71.60%
Market Cap
$538.28M
Return on Invested Capital (ROIC)
-18.90%
TTM Avg
-35.16%
3Y Avg
-27.40%
5Y Avg
-20.34%
Market Cap
$590.58M
Return on Invested Capital (ROIC)
-4.97%
TTM Avg
-6.49%
3Y Avg
-6.53%
5Y Avg
-6.86%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CorMedix Inc. (CRMD) | $564.85M | 27.87% | 23.49% | -30.49% | -37.39% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $559.96M | -43.41% | -39.91% | -39.91% | -39.91% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -45.62% | -46.61% | -61.97% | -71.18% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $580.12M | -56.99% | -66.45% | -57.50% | -60.06% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $554.05M | -25.42% | 25.46% | -12.61% | -20.42% |
| Delcath Systems, Inc. (DCTH)vs › | $546.13M | -0.81% | -8.59% | -110.96% | -102.03% |
| Immix Biopharma, Inc. (IMMX)vs › | $540.75M | -18.20% | -95.31% | -87.63% | -71.60% |
| 908 Devices Inc. (MASS)vs › | $538.28M | -18.90% | -35.16% | -27.40% | -20.34% |
| OrthoPediatrics Corp. (KIDS)vs › | $590.58M | -4.97% | -6.49% | -6.53% | -6.86% |
| Crescent Biopharma, Inc. (CBIO)vs › | $542.67M | -102.59% | -133.31% | -119.78% | -99.25% |
ROIC
27.9%
ROE
40.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 27.87% |
| 2026-03-31 | 27.59% |
| 2025-12-31 | 23.03% |
| 2025-09-30 | 16.84% |
| 2025-06-30 | 22.10% |
| 2025-03-31 | 12.56% |
| 2024-12-31 | -26.30% |
| 2024-09-30 | -86.22% |
| 2024-06-30 | -124.71% |
| 2024-03-31 | -93.43% |
| 2023-12-31 | -69.29% |
| 2023-09-30 | -49.76% |
| 2023-06-30 | -76.67% |
| 2023-03-31 | -63.43% |
| 2022-12-31 | -54.95% |
| 2022-09-30 | -52.64% |
| 2022-06-30 | -50.61% |
| 2022-03-31 | -48.25% |
| 2021-12-31 | -46.29% |
| 2021-09-30 | -39.53% |
| 2021-06-30 | -33.17% |
| 2021-03-31 | -35.49% |
| 2020-12-31 | -60.29% |
| 2020-09-30 | -74.85% |
| 2020-06-30 | -135.40% |
| 2020-03-31 | -100.47% |
| 2019-12-31 | -88.84% |
| 2019-09-30 | -47.00% |
| 2019-06-30 | -79.97% |
| 2019-03-31 | -94.02% |
| 2018-12-31 | -242.90% |
| 2018-03-31 | -4221.99% |
| 2017-12-31 | -457.70% |
| 2017-09-30 | -300.56% |
| 2017-06-30 | -196.73% |
| 2017-03-31 | -254.62% |
| 2016-12-31 | -138.99% |
| 2016-09-30 | -86.72% |
| 2016-06-30 | -57.65% |
| 2016-03-31 | -50.48% |
| 2015-12-31 | -48.92% |
| 2015-09-30 | -45.46% |
| 2015-06-30 | -37.17% |
| 2015-03-31 | -150.22% |
| 2014-12-31 | -242.41% |
| 2014-09-30 | -146.36% |
| 2014-06-30 | -107.76% |
| 2014-03-31 | -81.41% |
| 2013-12-31 | -379.94% |
| 2012-03-31 | -1407.11% |
| 2011-12-31 | -579.30% |
| 2011-09-30 | -1231.85% |
| 2011-06-30 | -248.48% |
| 2011-03-31 | -125.99% |
| 2010-12-31 | -116.98% |
| 2010-09-30 | -117.06% |
| 2010-06-30 | -98.65% |
| 2010-03-31 | -86.03% |
